ChineseInvestors.com Inc. (CIIX) to Seek Acquisition Target after CBD Biotech Spin-off
Growth by acquisition will be a priority following IPO spin-off, according to CIIX CEO Warren Wang CIIX reported significant revenue growth, with hemp and CBD sales increasing by eight times year-over-year Industry trend may indicate more hemp or marijuana being sourced from Columbia, or Thailand and other Asian locations, moving forward ChineseInvestors.com Inc. (OTCQB: CIIX) is currently planning an IPO of wholly owned foreign enterprise CBD Biotech, according to CEO Warren Wang. Wang said in a news release that the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early the following year. CIIX would then…